FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+26.79%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$12.4B
AUM Growth
+$12.4B
(+14%)
Cap. Flow
-$730M
Cap. Flow
% of AUM
-5.86%
Top 10 Holdings %
Top 10 Hldgs %
33.25%
Holding
138
New
31
Increased
25
Reduced
37
Closed
17
Top Buys
| 1 |
T-Mobile US
TMUS
|
$360M |
| 2 |
Aon
AON
|
$331M |
| 3 |
WUBA
58.COM INC
WUBA
|
$268M |
| 4 |
Bristol-Myers Squibb
BMY
|
$213M |
| 5 |
TIF
Tiffany & Co.
TIF
|
$186M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$1.65B |
| 2 |
Cigna
CI
|
$141M |
| 3 |
General Dynamics
GD
|
$139M |
| 4 |
Fidelity National Information Services
FIS
|
$138M |
| 5 |
Wabtec
WAB
|
$115M |
Sector Composition
| 1 | Healthcare | 42.69% |
| 2 | Communication Services | 18.47% |
| 3 | Technology | 10.46% |
| 4 | Financials | 7.55% |
| 5 | Industrials | 3.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
76
Amarin Corp
AMRN
$311M
| $21.6M | 0.17% | 3,125,000 -500,000 | -14% | -$3.46M |
|
|
NVTA
77
DELISTED
Invitae Corporation
NVTA
| $19.9M | 0.16% | 656,528 -1,218,772 | -65% | -$36.9M |
|
78
Zymeworks
ZYME
$1.12B
| $19.8M | 0.16% | 550,000 -1,200,000 | -69% | -$43.3M |
|
79
Howmet Aerospace
HWM
$70.2B
| $19M | 0.15% | +1,199,186 | New | +$19M |
|
80
Krystal Biotech
KRYS
$4.27B
| $18.6M | 0.15% | 450,000 +200,000 | +80% | +$8.28M |
|
|
PRNB
81
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $17.9M | 0.14% | 300,000 -84,674 | -22% | -$5.06M |
|
|
ZEAL
82
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $17.5M | 0.14% | 500,000 -250,000 | -33% | -$8.75M |
|
83
Liquidia Corp
LQDA
$2.38B
| $15.6M | 0.12% | +1,850,000 | New | +$15.6M |
|
|
TCDA
84
DELISTED
Tricida, Inc. Common Stock
TCDA
| $13.7M | 0.11% | 500,000 -500,000 | -50% | -$13.7M |
|
85
uniQure
QURE
$896M
| $13.5M | 0.11% | 300,000 +50,000 | +20% | +$2.25M |
|
86
Royalty Pharma
RPRX
$15.6B
| $13.4M | 0.11% | +275,000 | New | +$13.4M |
|
|
RC
87
Ready Capital
RC
$700M
| $11.7M | 0.09% | 1,350,226 +82,330 | +6% | +$715K |
|
88
Savara
SVRA
$567M
| $11.1M | 0.09% | 4,470,964 -354,122 | -7% | -$882K |
|
89
CRISPR Therapeutics
CRSP
$4.71B
| $11M | 0.09% | 150,000 -200,000 | -57% | -$14.7M |
|
|
CNST
90
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $10.5M | 0.08% | +350,000 | New | +$10.5M |
|
91
Pacific Biosciences
PACB
$393M
| $10.4M | 0.08% | 3,000,000 | – | – |
|
92
Akebia Therapeutics
AKBA
$833M
| $10.2M | 0.08% | 750,000 -500,000 | -40% | -$6.79M |
|
|
ATTO
93
DELISTED
Atento S.A.
ATTO
| $7.71M | 0.06% | +11,212,205 | New | +$7.71M |
|
|
AKUS
94
DELISTED
Akouos, Inc. Common Stock
AKUS
| $5.06M | 0.04% | +225,000 | New | +$5.06M |
|
|
AMTI
95
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $5.03M | 0.04% | +200,000 | New | +$5.03M |
|
96
Repare Therapeutics
RPTX
$71.7M
| $4.65M | 0.04% | +150,000 | New | +$4.65M |
|
|
ARYBU
97
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
| $4.64M | 0.04% | +400,000 | New | +$4.64M |
|
|
FUSN
98
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $4.37M | 0.04% | +250,000 | New | +$4.37M |
|
|
ISEE
99
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.83M | 0.03% | +750,000 | New | +$3.83M |
|
|
DMTK
100
DELISTED
DermTech, Inc. Common Stock
DMTK
| $2.58M | 0.02% | 194,675 -410,580 | -68% | -$5.43M |
|